Wednesday, February 17, 2021 3:17:06 PM
From CNN's Betsy Klein
White House Covid-19 response team testing coordinator Carole Johnson announced new steps from the Biden administration to increase testing efforts and capacity across the country, focused on testing for schools and underserved communities, testing supplies, and genomic sequencing as a “bridge” before Congress is able to pass a stimulus package.
“We need to test broadly and rapidly to turn the tide of this pandemic. But we still don’t have enough testing and we don’t have enough testing in all the places it needs to be. Today, we’re taking a critical step along that path,” she said at Wednesday’s virtual Covid briefing.
She outlined a new $1.6 billion federal investment in three key areas:
• $650 million in funding for testing for schools and underserved populations: She said this will “serve only as a pilot” until Congress can pass a relief package. It will create regional coordinating centers that will partner with labs to support schools and underserved committees, including homeless shelters and other places that “don’t have the resources or the bandwidth to build partnerships with academic or commercial testing labs.”
• $815 million for domestic manufacturing of testing supplies: This money will address what Johnson described as a “shortage of critical supplies and raw materials,” including pipette tips, the specialized paper used in the antigen test, and the specialized molded plastics needed to house testing reagents.
• Nearly $200 million toward genome sequencing: The funding will “result in a three-fold increase to the CDC’s genomic sequencing capacity,” bringing the US to 25,000 samples per week, which, she said, will help to quickly identify variants sooner and “better target our efforts to stop the spread.”
Johnson said that these steps are “a significant help in the short term” but are still “far from what’s necessary to meet the needs of testing in communities across the country,” describing the funding as a “bridge until Congress passes the American Rescue Plan.”
“We need to build the capacity to produce these materials, or we'll continue to face shortages that will sidetrack our work in expanding access to testing,” she added.
Opti
Hebrews 11:6 And without faith it is impossible to please Him, for he who comes to God must believe that He is and that He is a rewarder of those who seek Him.
Recent CODX News
- Co-Diagnostics, Inc. to Host Booth and Deliver Presentation at APRC 2024 in Taiwan • PR Newswire (US) • 04/24/2024 01:30:00 PM
- Co-Diagnostics, Inc. Inaugurates New Manufacturing Facility in Utah with Ribbon Cutting Event • PR Newswire (US) • 04/12/2024 01:30:00 PM
- Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions • PR Newswire (US) • 04/04/2024 01:30:00 PM
- Co-Diagnostics, Inc. CEO Delivers Manufacturing and Commercialization Update in Conference Keynote Address • PR Newswire (US) • 03/21/2024 01:30:00 PM
- Co-Diagnostics, Inc. CEO to Deliver Keynote Address at MarketsandMarkets 2024 in London, England • PR Newswire (US) • 03/18/2024 01:30:00 PM
- Co-Diagnostics, Inc. Reports Full Year 2023 Financial Results • PR Newswire (US) • 03/14/2024 08:01:00 PM
- Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Influenza Multiplex PCR Test • PR Newswire (US) • 03/07/2024 02:30:00 PM
- Co-Diagnostics, Inc. Announces Fourth Quarter and Full Year 2023 Earnings Release Date and Webcast • PR Newswire (US) • 02/29/2024 02:30:00 PM
- Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for February 2024 • PR Newswire (US) • 02/01/2024 02:30:00 PM
- Co-Diagnostics, Inc. to Host Booth at CES 2024 January 9-12 • PR Newswire (US) • 01/03/2024 02:30:00 PM
- Co-Diagnostics, Inc. Completes Submission to FDA for Co-Dx PCR Pro • PR Newswire (US) • 12/27/2023 02:30:00 PM
- Co-Diagnostics, Inc. to Participate in the Piper Sandler 35th Annual Healthcare Conference in New York City on November 30, 2023 • PR Newswire (US) • 11/29/2023 02:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:50:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:38:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/27/2023 09:37:56 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:05:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 09:01:35 PM
- Co-Diagnostics, Inc. Reports Third Quarter 2023 Financial Results • PR Newswire (US) • 11/09/2023 09:01:00 PM
- Co-Diagnostics, Inc. Announces Additional Grant Award for Tuberculosis Test in Development • PR Newswire (US) • 11/02/2023 01:30:00 PM
- Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023 • PR Newswire (US) • 10/31/2023 01:30:00 PM
- Co-Diagnostics, Inc. Announces Third Quarter 2023 Earnings Release Date and Webcast • PR Newswire (US) • 10/26/2023 01:30:00 PM
- Co-Diagnostics, Inc. to Host Booth at CASMET Symposium October 23-25 • PR Newswire (US) • 10/23/2023 01:30:00 PM
- Co-Diagnostics, Inc. to Host Booth at Medlab Africa 2023 in Johannesburg, South Africa • PR Newswire (US) • 10/16/2023 01:30:00 PM
- Co-Diagnostics, Inc. to Participate in the 2023 UHCA/UCAL Fall Convention & Expo on Sept 27-28 • PR Newswire (US) • 09/27/2023 01:30:00 PM
- Co-Diagnostics, Inc. to Participate in 6th ACTC Conference in Skiathos, Greece • PR Newswire (US) • 09/22/2023 01:30:00 PM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM
Avant Technologies Launches Advanced AI Supercomputing Network and Expansive Data Solutions • AVAI • Apr 23, 2024 8:00 AM
BestGrowthStocks.com Issues Comprehensive Analysis of Triller Merger with AGBA Group Holding Limited • AGBA • Apr 22, 2024 1:00 PM
Cannabix Technologies to Present Marijuana Breathalyzer Technology at International Association for Chemical Testing (IACT) Conference in California • BLO • Apr 22, 2024 8:49 AM